Recomendamos intentar perder de 1 a 2 libras por semana, pero su proveedor de atencin mdica puede brindarle orientacin personalizada segn su respuesta individual
In 2025, the company reported a modest +0.99% YoY revenue growth, but the underlying story is more interesting: Dupixent ($17.8B) remains the clear growth engine, benefiting from expanding indications like COPD and broader patient reach, while the EYLEA franchise ($7.89B) continues to be a core contributor despite facing biosimilar pressure, supported by the transition to EYLEA HD, and Libtayo ($1.45B) is steadily gaining ground in oncology, particularly in lung cancer settings
A novel cAMP-biased Mechanism Ecnoglutide injection represents the world's first approved long-acting cAMP-biased glucagon-like peptide-1 (GLP-1) receptor agonist
But infusing a molecule that disappears in 2 minutes is not practical medicine
Wasted Money: Buying patches without proven GLP-1 content is often a waste of funds
GLP-1 considerations for women include interactions with hormonal contraceptives, effects during perimenopause, and special nutritional considerations
